US-Based Cybersecurity Firm AlgoSec Is Said to Mull London IPO
THE SO WHAT
A US cybersecurity company eyeing a London listing is another test of whether UK markets can become a real venue for scaled tech IPOs. If you’re a late-stage security or infra company, cross-listing and venue arbitrage just became a more practical lever in your capital markets playbook.
READ THE SOURCE
MORE FROM THE WIRE
Startups & VentureOzlo’s Sleepbuds 2 build on Bose’s sleep earbud legacy
Ozlo extending Bose’s shelved Sleepbuds line shows there’s durable demand for narrow, high-compliance wellness hardware, not just general-purpose earbuds. For consumer-device teams, this is a reminder that focused, single-job products can survive big-brand exits if they solve a chronic problem well.
Startups & VentureSaudi prince buys 5% stake in Lucid Motors
A Saudi prince taking a 5% stake in Lucid — amid speculation about going private — underscores how capital-intensive EV manufacturing is migrating toward sovereign and strategic investors. If you’re in hardware-heavy mobility, expect your future cap table to look more like infrastructure finance than classic venture.
Startups & VentureThe Italian state just backed €500m for the company that owns AOL
Italy’s €500m state-guaranteed loan to Bending Spoons signals governments are willing to underwrite acquisitive software platforms as national champions. If you’re competing with them in consumer apps or tooling, model them less as a startup and more as a state-backed consolidator with cheaper capital.
Startups & VentureOnly 27% of US hospitals can run an EEG. Epitel raised $26m for the rest
Epitel’s $26m Series B for at-home wireless EEGs is a bet that access, not technology, is the real constraint — with 73% of US hospitals lacking EEG capability. Healthcare operators should be scanning for similar "infrastructure-light" diagnostics that shift monitoring into the home and bypass capital-intensive hospital installs.